These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial. Elkayam U, Bitar F. Am J Cardiol; 2005 Oct 10; 96(7B):37i-43i. PubMed ID: 16226934 [Abstract] [Full Text] [Related]
9. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug. Münzel T, Kurz S, Rajagopalan S, Thoenes M, Berrington WR, Thompson JA, Freeman BA, Harrison DG. J Clin Invest; 1996 Sep 15; 98(6):1465-70. PubMed ID: 8823313 [Abstract] [Full Text] [Related]
10. The effect of hydralazine on the development of tolerance to continuous nitroglycerin. Parker JD, Parker AB, Farrell B, Parker JO. J Pharmacol Exp Ther; 1997 Feb 15; 280(2):866-75. PubMed ID: 9023301 [Abstract] [Full Text] [Related]
11. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Massie B, Chatterjee K, Werner J, Greenberg B, Hart R, Parmley WW. Am J Cardiol; 1977 Nov 15; 40(5):794-801. PubMed ID: 411364 [Abstract] [Full Text] [Related]